Celegene

By Laura Lovett 02:51 pm July 9, 2019
This morning precision medicine company GNS Healthcare announced a $23 million Series D raise. This latest investment round was led by Cigna Ventures with participation from Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman, the former CEO of Caesar and division president of Aetna.  WHAT THEY DO The company’s platform, dubbed REFS (Reverse Engineering...